Authors: Farrugia, D Lewis, R

Citation: D. Farrugia et R. Lewis, Chemotherapy and quality of life in advanced NSCLC, BR J CANC, 85(1), 2001, pp. 137-137

Authors: Farrugia, D Ansell, W Singh, M Philp, T Chinegwundoh, F Oliver, RTD

Citation: D. Farrugia et al., Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy, BJU INT, 85(9), 2000, pp. 1069-1073

Authors: Piggott, M Farrugia, D Otite, U Oliver, RTD Crake, T

Citation: M. Piggott et al., Renal cell carcinoma presenting with cardiac failure, HOSP MED, 61(11), 2000, pp. 804-805

Authors: Oliver, RTD Farrugia, D Ansell, W Willams, G Chinegwundoh, F

Citation: Rtd. Oliver et al., Potential of intermittent hormone therapy for M+ and M0 prostate cancer patients, PROSTATE C, 3(4), 2000, pp. 286-289

Authors: Farrugia, D Oliver, RT

Citation: D. Farrugia et Rt. Oliver, Staging of bladder cancer, OX MED PUBL, 1999, pp. 213-224

Authors: Farrugia, D Johnston, PG

Citation: D. Farrugia et Pg. Johnston, Pharmacodynamic measurements and predictors of response to thymidylate synthase inhibitors, CANC DRUG, 1999, pp. 383-396